Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

(2017) Pierre Nahon et al.   GASTROENTEROLOGY

Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013

(2016) Kathleen N. Ly et al.   CLINICAL INFECTIOUS DISEASES

Self-Efficacy and Adherence to Antiviral Treatment for Chronic Hepatitis C

(2015) Jason E. Bonner et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs

(2015) John W. Ward et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

(2012) Christoph Welsch et al.   GUT

Patient and Provider Characteristics Associated with the Decision of HIV Coinfected Patients to Start Hepatitis C Treatment

(2011) Karen Chan Osilla et al.   AIDS PATIENT CARE AND STDS

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY